AnaptysBio CEO to Participate in H.C. Wainwright Conference

AnaptysBio, Inc. announced that Daniel Faga, its President and Chief Executive Officer, is scheduled to participate in a fireside chat. The event will take place at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference on Wednesday, May 6, 2026, starting at 1:30pm ET. The company focuses on managing financial collaborations for Jemperli with GSK and imsidolimab with Vanda, aiming to protect and return royalty value to shareholders.